Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection

J Allergy Clin Immunol. 2011 Nov;128(5):1128-30. doi: 10.1016/j.jaci.2011.09.009. Epub 2011 Oct 1.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Allergic Agents / adverse effects*
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Dermatitis, Atopic / complications*
  • Dermatitis, Atopic / drug therapy*
  • Humans
  • Male
  • Receptors, Interleukin-6 / antagonists & inhibitors
  • Superinfection / complications*
  • Young Adult

Substances

  • Anti-Allergic Agents
  • Antibodies, Monoclonal, Humanized
  • Receptors, Interleukin-6
  • tocilizumab